Skip to main content

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) Investor Securities Class Action Lawsuit 08/03/2023

  • If you purchased a significant amount of shares of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) between January 28, 2021, and July 28, 2023, and / or if you purchased any NASDAQ: APLS shares prior to January 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: October 2, 2023. NASDAQ: APLS investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

February 8, 2024 - An amended complaint was filed. August 03, 2023  - An investor in shares of Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) filed a lawsuit in the U.S. District Court for the District of Delaware over alleged violations of Federal Securities Laws by Apellis Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between January 2...

You must register (for free) or login to view the entire case.